TIENGO, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 9.030
AS - Asia 3.218
EU - Europa 1.778
AF - Africa 786
SA - Sud America 584
OC - Oceania 83
Continente sconosciuto - Info sul continente non disponibili 51
Totale 15.530
Nazione #
US - Stati Uniti d'America 8.596
SG - Singapore 1.148
CN - Cina 660
HK - Hong Kong 383
BR - Brasile 324
VN - Vietnam 273
FI - Finlandia 222
SE - Svezia 199
DE - Germania 181
FR - Francia 123
UA - Ucraina 120
GB - Regno Unito 92
RU - Federazione Russa 79
PL - Polonia 70
IT - Italia 69
AR - Argentina 46
IN - India 41
TR - Turchia 38
GT - Guatemala 35
ZA - Sudafrica 35
TT - Trinidad e Tobago 34
IE - Irlanda 32
MX - Messico 32
NL - Olanda 32
GH - Ghana 31
IL - Israele 31
ES - Italia 30
IQ - Iraq 30
MY - Malesia 29
CV - Capo Verde 28
CW - ???statistics.table.value.countryCode.CW??? 28
MD - Moldavia 28
MN - Mongolia 28
PY - Paraguay 28
DJ - Gibuti 27
EC - Ecuador 27
IS - Islanda 27
UZ - Uzbekistan 27
ID - Indonesia 26
KE - Kenya 26
PE - Perù 26
RS - Serbia 26
TN - Tunisia 26
BB - Barbados 25
MA - Marocco 25
PH - Filippine 25
SK - Slovacchia (Repubblica Slovacca) 25
TH - Thailandia 25
TZ - Tanzania 25
DZ - Algeria 24
PR - Porto Rico 24
UG - Uganda 24
UY - Uruguay 24
VE - Venezuela 24
BE - Belgio 23
CZ - Repubblica Ceca 23
HN - Honduras 23
HR - Croazia 23
KZ - Kazakistan 23
MR - Mauritania 23
PA - Panama 23
SN - Senegal 23
AE - Emirati Arabi Uniti 22
AT - Austria 22
BG - Bulgaria 22
BY - Bielorussia 22
CL - Cile 22
CO - Colombia 22
CY - Cipro 22
HT - Haiti 22
JP - Giappone 22
NO - Norvegia 22
RO - Romania 22
AM - Armenia 21
CR - Costa Rica 21
DO - Repubblica Dominicana 21
GF - Guiana Francese 21
LY - Libia 21
MG - Madagascar 21
YT - Mayotte 21
ZM - Zambia 21
AL - Albania 20
BO - Bolivia 20
JO - Giordania 20
ME - Montenegro 20
NC - Nuova Caledonia 20
NE - Niger 20
PS - Palestinian Territory 20
SD - Sudan 20
TJ - Tagikistan 20
XK - ???statistics.table.value.countryCode.XK??? 20
ZW - Zimbabwe 20
AO - Angola 19
BS - Bahamas 19
DK - Danimarca 19
KG - Kirghizistan 19
LA - Repubblica Popolare Democratica del Laos 19
NZ - Nuova Zelanda 19
PK - Pakistan 19
PT - Portogallo 19
Totale 14.629
Città #
Fairfield 1.323
Woodbridge 783
Chandler 670
Houston 635
Ashburn 623
Singapore 587
Jacksonville 584
Wilmington 484
Ann Arbor 483
Seattle 474
Cambridge 459
Hong Kong 368
Princeton 201
Beijing 193
Boardman 181
Dong Ket 155
Santa Clara 124
Roxbury 123
San Diego 123
Nanjing 93
Helsinki 74
Guangzhou 68
Des Moines 65
Medford 62
Bytom 53
Los Angeles 46
Ho Chi Minh City 42
Shenyang 34
Hebei 30
Accra 28
Hanoi 28
Dublin 27
Shanghai 27
Council Bluffs 26
Nanchang 26
Norwalk 26
São Paulo 26
Tashkent 26
Ulan Bator 26
Chicago 25
Praia 25
Dakar 23
Guatemala City 23
Munich 23
New York 23
Kampala 22
Montevideo 22
Nairobi 22
Panama City 22
Reykjavik 21
Bridgetown 20
Jiaxing 20
Nouakchott 20
Noumea 20
Willemstad 20
Amman 19
Dar es Salaam 19
Djibouti 19
Dushanbe 19
Lusaka 19
Bishkek 18
Harare 18
Managua 18
Nassau 18
Turku 18
Yerevan 18
Andorra la Vella 17
Antananarivo 17
Ljubljana 17
Podgorica 17
San José 17
Abidjan 16
Baku 16
Buffalo 16
Castries 16
Chisinau 16
Lima 16
Minsk 16
Niamey 16
Vienna 16
Cayenne 15
Changsha 15
Cotonou 15
Johannesburg 15
Kigali 15
Zagreb 15
Dili 14
George Town 14
Kingstown 14
Kuala Lumpur 14
Libreville 14
Mamoudzou 14
Tallinn 14
London 13
Luanda 13
Phnom Penh 13
Pristina 13
Riga 13
San Francisco 13
Sofia 13
Totale 10.468
Nome #
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 203
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 200
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 199
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 198
Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects 195
EFFECTS OF CHRONIC ALCOHOL INTAKE ON CARBOHYDRATE AND LIPID-METABOLISM IN SUBJECTS WITH TYPE-II (NON-INSULIN-DEPENDENT) DIABETES 192
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 183
Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria. 180
Endothelial progenitor cells and the diabetic paradox. 176
Abnormal cytoskeletal protein expression in cultured skin fibroblasts form type 1 diabetes mellitus patiens with nephropathy: A proteomic approach. 175
Circulating CD34(+) cells, metabolic syndrome, and cardiovascular risk 166
Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness. 166
Number and function of endothelial progenitor cells as a marker of severity of diabetic vasculopathy. 166
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 165
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. 165
Two cases of statin-induced rhabdomyolysis associated with mononeuropathy. 164
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. 163
Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and Type I diabetic subjects 161
Peripheral blood CD34(+)KDR(+) endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population 161
Mechanisms of acute and chronic hypoglycemic action of gliclazide 161
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 159
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. 158
Dose-response curves of effects of insulin on leucine kinetics in humans. 158
A 2026 D peptide as the putative pancreatic cancer-associated diabetogenic factor 157
Arterio-venous gradient of endothelial progenitor cells across renal artery stenosis. 153
The metabolic syndrome, diabetes and lung dysfunction. 153
Carbohydrate and lipid metabolism in cirrhosis. Evidence that hepatic uptake of gluconeogenic precursors and of free fatty acids depends on effective hepatic flow. 152
Metformin treatment of rats with diet-induced overweight and hypertriglyceridemia decreases plasma triglyceride concentrations, while decreasing triglyceride and increasing ketone body output by the isolated perfused liver 151
Characteristics and outcomes of the hyperglycemic hyperosmolar non-ketotic syndrome in a cohort of 51 consecutive cases at a single center. 151
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 150
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 150
Hepatic lipid metabolism and non-alcoholic fatty liver disease. 149
Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: A low molecular weight factor possibly involved 142
Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man. 140
Characteristics and mortality of type 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia 140
Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects 139
Role of anti-granulocyte Fab ' fragment antibody scintigraphy (LeukoScan) in evaluating bone infection: acquisition protocol, interpretation criteria and clinical results 138
Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. 137
Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients 135
Insulin generates free radicals in human fibroblasts ex vivo by a protein kinase C-dependent mechanism, which is inhibited by pravastatin 133
Non esterified fatty acids and endothelial dysfunction 133
Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes 133
In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine 132
Continuous subcutaneous glucose monitoring in diabetic patients - A multicenter analysis 131
Circulating progenitor cells in the natural history of type 2 diabetes mellitus 130
Characteristics and mortality oftype 2 diabetic patients hospitalized for severe iatrogenic hypoglycemia. 130
Effects of insulin treatment on ketone body production and carnitine-palmitoyl-transferase (CPT) activity in the isolated perfused liver from streptozotocin diabetic rats. 130
Sequelae of acute hypoglycaemia on 24 hour blood pressure and metabolic parameters in normal and type 1 (insulin-dependent) diabetic individuals. 130
Glucose tolerance is negatively associated with circulating progenitor cell levels. 130
The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and Type 1 (insulin-dependent) diabetic humans 129
Effects of metformin treatment on whole-body and splanchnic amino acid turnover in mild type 2 diabetes. 128
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus 127
Insulin infusion normalizes fasting and postprandial albumin and fibrinogen synthesis in type 1 diabetes mellitus 127
Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance. 127
The metabolic syndrome, diabetes and lungdysfunction. 124
The effect of continuous subcutaneous insulin infusion treatment on proliferative diabetic retinopathy. 124
The use of degrees of certainty to evaluate knowledge 122
Glucose tolerance during moderate alcohol intake: Insights on insulin action from glucose/lactate dynamics 122
Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients 120
Hyperalaninaemia is an early feature of diabetes secondary to total pancreatectomy. 120
Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase. 120
Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes 119
In situ protein Kinase C activity is increased in cultured fibroblasts from Type 1 diabetic patients with nephropathy 119
A 2030 D peptide as the putative pancreatic cancer-associated diabetogenic factor 119
Early myocardial dysfunction in the diabetic heart: Current research and clinical applications 118
Alcohol impairs insulin sensitivity in normal subjects. 118
Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels. 118
Prevalence of microangiopathic complications in hyperglycemia secondary to pancreatic disease. 118
Effects of oral amino acid supplementation on myocardial function in patients with type 2 diabetes mellitus 117
First isolation of Burkholderia cepacia from a deep neck abscess in a diabetic patient successfully treated with hyperbaric oxygen. 117
Ketone body metabolism in NIDDM. Effect of sulfonylurea treatment 114
Plasma free fatty acids and endothelium-dependent vasodilation: effect of chain-length and cyclooxygenase inhibition 113
Mechanisms of fasting hypoglycemia and concomitant insulin resistance in insulinoma patients 113
Regulation of postprandial whole-body proteolysis in insulin-deprived IDDM. 113
Relationship between plasma leucine concentration and clearance in normal and type 1 diabetic subjects. 112
Educating diabetic patients about insulin use: changes over time in certainty and correctness of knowledge. 112
Continuous glucose monitoring in conditions other than diabetes 110
The effects of oral amino acid intake on ambulatory capacity in elderly subjects 109
Continuous subcutaneous insulin infusion (CSII) in Italy 109
Model of the kinetics of ketone bodies in humans. 109
Ketone body metabolism in normal and diabetic human skeletal muscle. 107
Effect of streptozotocin in a case of glucagon-secreting malignant islets-cell tumor. 106
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. 105
Effect of acute ketosis on the endothelial function of type 1 diabetic patients: the role of nitric oxide. 103
Forearm ketone body metabolism in normal and in insulin-dependent diabetic patients. 103
Extreme but asymptomatic hypergastrinemia with gastroparesis in a young woman with insulin dependent diabetes mellitus. 103
Effect of different times of administration of a single ethanol dose on insulin action, insulin secretion and redox state. 102
High blood ketone body concentration in type 2 non-insulin dependent diabetic patients. 102
PROTEIN METABOLISM IN GLUCAGONOMA. 101
Role of intra-arterial calcium injection test and venous sampling (IACI) as localizing procedure in insulinomas. 101
INTRA-ARTERIAL CALCIUM INJECTION TEST AS LOCALIZING PROCEDURE IN INSULINOMAS. 101
Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: Correlation with plasma glucagon concentrations 101
A randomized crossover study to compare continuous subcutaneous insulin infusion (CSII) with multiple daily injection (MDI) in type 1 diabetic patients previously treated with CSII 100
A post-hypoglycaemic increase of lactate can rescue cognitive function and counterregulatory responses to hypoglycaemia 99
Left ventricular mass in type 2 diabetes mellitus. A study employing a simple ECG index: The Cornell voltage 98
Accuracy of continuous subcutaneous glucose monitoring in detecting hypoglycemia in diabetic patients 98
Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients 96
Effect of insulin replacement on intermediary metabolism in diabetes secondary to pancreatectomy. 96
Surgical removal of insulinoma restores glucose recovery from hypoglycaemia but does not normalize insulin action. 96
Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. 94
Totale 13.342
Categoria #
all - tutte 48.046
article - articoli 42.489
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 898
Totale 91.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.198 0 0 0 0 87 164 39 142 230 118 186 232
2021/20221.633 23 191 219 109 64 120 74 162 98 25 200 348
2022/20231.319 248 142 9 179 206 174 1 110 171 7 57 15
2023/2024503 18 87 56 38 30 32 16 9 16 80 52 69
2024/20252.183 6 182 136 84 297 37 85 144 195 74 409 534
2025/20264.148 236 822 1.210 1.363 517 0 0 0 0 0 0 0
Totale 15.535